Skip to content

Clinical trials

Phase 4 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 4 Clear all

122 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20026
20038
20045
20054
20066
20074
20082
20093
20102
20117
20125
20133
20144
20156
20166
20176
20182
20196
20201
20213
20223
20235
202412
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Unknown status16
Recruiting14
Terminated13
Active, not recruiting6
Not yet recruiting5
Suspended2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Novartis4
GlaxoSmithKline3
Sanofi3
Astellas Pharma Inc2
AstraZeneca2
Blue Earth Diagnostics2
Brigham and Women's Hospital2
Columbia University2
Corewell Health East2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms122
Breast Neoplasms9
Neoplasms8
Neoplasm Metastasis5
Kidney Neoplasms4
Pain4
Colonic Neoplasms3
Kidney Diseases3
Prostatic Hyperplasia3
Anxiety Disorders2

Trials

Showing 51 to 75 of 122. Each trial links to its page on Pharma Observatory.

22 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.